Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Mar;93(3):1179–1185. doi: 10.1172/JCI117071

Cocaine differentially inhibits neuronal differentiation and proliferation in vitro.

D Zachor 1, J K Cherkes 1, C T Fay 1, I Ocrant 1
PMCID: PMC294069  PMID: 8132758

Abstract

The outcome of in utero cocaine exposure is unclear. To determine if cocaine affects neuronal growth and differentiation, we used PC-12 cells, which have a mitogenic response to IGF-I and differentiate into neurons on exposure to nerve growth factor. Differentiation was quantified as neurite extension after a 72-h exposure to 20 ng/ml nerve growth factor (dosage at 50% maximal effectiveness) and cocaine doses ranging from 0.01 to 10 micrograms/ml. The results were 49 +/- 2, 40 +/- 3, 29 +/- 2, 23 +/- 2, and 12 +/- 2% differentiation with respective cocaine concentrations of 0, 0.01, 0.1, 1, and 10 micrograms/ml (P < 0.0001). Cocaine stability studies showed insignificant spontaneous hydrolysis under the conditions of this study. Cocaine did not affect cell viability or number, but had a relatively modest, statistically significant (P < 0.001) inhibitory effect on IGF-I-stimulated thymidine incorporation. The dose-response curves for differentiation vs mitogenic response differed significantly (P = 0.021). Therefore, cocaine inhibition of these processes is probably mediated by different mechanisms, and not caused by generalized toxicity. To our knowledge, this is the first demonstration of cocaine effects on neuronal multiplication and differentiation in vitro. The results suggest in utero exposure may directly impair brain development.

Full text

PDF
1179

Images in this article

1182Image
on p.1182
1182Image
on p.1182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbari H. M., Kramer H. K., Whitaker-Azmitia P. M., Spear L. P., Azmitia E. C. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 1992 Feb 14;572(1-2):57–63. doi: 10.1016/0006-8993(92)90450-n. [DOI] [PubMed] [Google Scholar]
  2. Anderson-Brown T., Slotkin T. A., Seidler F. J. Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res. 1990 Dec 24;537(1-2):197–202. doi: 10.1016/0006-8993(90)90358-i. [DOI] [PubMed] [Google Scholar]
  3. Bauchner H., Zuckerman B., McClain M., Frank D., Fried L. E., Kayne H. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr. 1988 Nov;113(5):831–834. doi: 10.1016/s0022-3476(88)80009-x. [DOI] [PubMed] [Google Scholar]
  4. Chasnoff I. J., Burns W. J., Schnoll S. H., Burns K. A. Cocaine use in pregnancy. N Engl J Med. 1985 Sep 12;313(11):666–669. doi: 10.1056/NEJM198509123131105. [DOI] [PubMed] [Google Scholar]
  5. Chasnoff I. J., Griffith D. R., Freier C., Murray J. Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics. 1992 Feb;89(2):284–289. [PubMed] [Google Scholar]
  6. Chasnoff I. J., Griffith D. R., MacGregor S., Dirkes K., Burns K. A. Temporal patterns of cocaine use in pregnancy. Perinatal outcome. JAMA. 1989 Mar 24;261(12):1741–1744. [PubMed] [Google Scholar]
  7. Clark G. D., Rosenzweig I. B., Raisys V., Callahan C. M., Grant T. M., Streissguth A. P. The analysis of cocaine and benzoylecgonine in meconium. J Anal Toxicol. 1992 Jul-Aug;16(4):261–263. doi: 10.1093/jat/16.4.261. [DOI] [PubMed] [Google Scholar]
  8. Clow D. W., Hammer R. P., Jr, Kirstein C. L., Spear L. P. Gestational cocaine exposure increases opiate receptor binding in weanling offspring. Brain Res Dev Brain Res. 1991 Apr 24;59(2):179–185. doi: 10.1016/0165-3806(91)90098-4. [DOI] [PubMed] [Google Scholar]
  9. DeVane C. L., Simpkins J. W., Miller R. L., Braun S. B. Tissue distribution of cocaine in the pregnant rat. Life Sci. 1989;45(14):1271–1276. doi: 10.1016/0024-3205(89)90129-x. [DOI] [PubMed] [Google Scholar]
  10. Doberczak T. M., Shanzer S., Senie R. T., Kandall S. R. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr. 1988 Aug;113(2):354–358. doi: 10.1016/s0022-3476(88)80283-x. [DOI] [PubMed] [Google Scholar]
  11. Dominguez R., Aguirre Vila-Coro A., Slopis J. M., Bohan T. P. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child. 1991 Jun;145(6):688–695. doi: 10.1001/archpedi.1991.02160060106030. [DOI] [PubMed] [Google Scholar]
  12. Dow-Edwards D. L. Cocaine effects on fetal development: a comparison of clinical and animal research findings. Neurotoxicol Teratol. 1991 May-Jun;13(3):347–352. doi: 10.1016/0892-0362(91)90082-8. [DOI] [PubMed] [Google Scholar]
  13. Dow-Edwards D. L., Freed L. A., Fico T. A. Structural and functional effects of prenatal cocaine exposure in adult rat brain. Brain Res Dev Brain Res. 1990 Dec 15;57(2):263–268. doi: 10.1016/0165-3806(90)90052-z. [DOI] [PubMed] [Google Scholar]
  14. Dow-Edwards D. L., Freed L. A., Milhorat T. H. Stimulation of brain metabolism by perinatal cocaine exposure. Brain Res. 1988 Jul 1;470(1):137–141. doi: 10.1016/0165-3806(88)90209-x. [DOI] [PubMed] [Google Scholar]
  15. Dow-Edwards D. L. Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann N Y Acad Sci. 1989;562:280–289. doi: 10.1111/j.1749-6632.1989.tb21026.x. [DOI] [PubMed] [Google Scholar]
  16. Evans M. A., Morarity T. Analysis of cocaine and cocaine metabolites by high pressure liquid chromatography. J Anal Toxicol. 1980 Jan-Feb;4(1):19–22. doi: 10.1093/jat/4.1.19. [DOI] [PubMed] [Google Scholar]
  17. Farrar H. C., Kearns G. L. Cocaine: clinical pharmacology and toxicology. J Pediatr. 1989 Nov;115(5 Pt 1):665–675. doi: 10.1016/s0022-3476(89)80640-7. [DOI] [PubMed] [Google Scholar]
  18. Frank D. A., Zuckerman B. S., Amaro H., Aboagye K., Bauchner H., Cabral H., Fried L., Hingson R., Kayne H., Levenson S. M. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988 Dec;82(6):888–895. [PubMed] [Google Scholar]
  19. Fujita K., Lazarovici P., Guroff G. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ Health Perspect. 1989 Mar;80:127–142. doi: 10.1289/ehp.8980127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Greene L. A., Tischler A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424–2428. doi: 10.1073/pnas.73.7.2424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gressens P., Kosofsky B. E., Evrard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci Lett. 1992 Jun 8;140(1):113–116. doi: 10.1016/0304-3940(92)90694-3. [DOI] [PubMed] [Google Scholar]
  22. Henderson M. G., McConnaughey M. M., McMillen B. A. Long-term consequences of prenatal exposure to cocaine or related drugs: effects on rat brain monoaminergic receptors. Brain Res Bull. 1991 Jun;26(6):941–945. doi: 10.1016/0361-9230(91)90261-h. [DOI] [PubMed] [Google Scholar]
  23. Hime G. W., Hearn W. L., Rose S., Cofino J. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry. J Anal Toxicol. 1991 Sep-Oct;15(5):241–245. doi: 10.1093/jat/15.5.241. [DOI] [PubMed] [Google Scholar]
  24. Hutchings D. E., Fico T. A., Dow-Edwards D. L. Prenatal cocaine: maternal toxicity, fetal effects and locomotor activity in rat offspring. Neurotoxicol Teratol. 1989 Jan-Feb;11(1):65–69. doi: 10.1016/0892-0362(89)90087-1. [DOI] [PubMed] [Google Scholar]
  25. Inaba T., Stewart D. J., Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther. 1978 May;23(5):547–552. doi: 10.1002/cpt1978235547. [DOI] [PubMed] [Google Scholar]
  26. Kennard M. J. Cocaine use during pregnancy: fetal and neonatal effects. J Perinat Neonatal Nurs. 1990 Apr;3(4):53–63. doi: 10.1097/00005237-199004000-00008. [DOI] [PubMed] [Google Scholar]
  27. Lutiger B., Graham K., Einarson T. R., Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology. 1991 Oct;44(4):405–414. doi: 10.1002/tera.1420440407. [DOI] [PubMed] [Google Scholar]
  28. Martz R., Donnelly B., Fetterolf D., Lasswell L., Hime G. W., Hearn W. L. The use of hair analysis to document a cocaine overdose following a sustained survival period before death. J Anal Toxicol. 1991 Sep-Oct;15(5):279–281. doi: 10.1093/jat/15.5.279. [DOI] [PubMed] [Google Scholar]
  29. Masoud A. N., Krupski D. M. High-performance liquid chromatographic analysis of cocaine in human plasma. J Anal Toxicol. 1980 Nov-Dec;4(6):305–310. doi: 10.1093/jat/4.6.305. [DOI] [PubMed] [Google Scholar]
  30. Minabe Y., Ashby C. R., Jr, Heyser C., Spear L. P., Wang R. Y. The effects of prenatal cocaine exposure on spontaneously active midbrain dopamine neurons in adult male offspring: an electrophysiological study. Brain Res. 1992 Jul 17;586(1):152–156. doi: 10.1016/0006-8993(92)91387-t. [DOI] [PubMed] [Google Scholar]
  31. Raum W. J., McGivern R. F., Peterson M. A., Shryne J. H., Gorski R. A. Prenatal inhibition of hypothalamic sex steroid uptake by cocaine: effects on neurobehavioral sexual differentiation in male rats. Brain Res Dev Brain Res. 1990 May 1;53(2):230–236. doi: 10.1016/0165-3806(90)90011-m. [DOI] [PubMed] [Google Scholar]
  32. Recio-Pinto E., Lang F. F., Ishii D. N. Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2562–2566. doi: 10.1073/pnas.81.8.2562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rivkin M., Gilmore H. E. Generalized seizures in an infant due to environmentally acquired cocaine. Pediatrics. 1989 Dec;84(6):1100–1102. [PubMed] [Google Scholar]
  34. Rodning C., Beckwith L., Howard J. Prenatal exposure to drugs: behavioral distortions reflecting CNS impairment? Neurotoxicology. 1989 Fall;10(3):629–634. [PubMed] [Google Scholar]
  35. Schubert D., Heinemann S., Kidokoro Y. Cholinergic metabolism and synapse formation by a rat nerve cell line. Proc Natl Acad Sci U S A. 1977 Jun;74(6):2579–2583. doi: 10.1073/pnas.74.6.2579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Singer L. T., Garber R., Kliegman R. Neurobehavioral sequelae of fetal cocaine exposure. J Pediatr. 1991 Oct;119(4):667–672. doi: 10.1016/s0022-3476(05)82426-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Spear L. P., Kirstein C. L., Bell J., Yoottanasumpun V., Greenbaum R., O'Shea J., Hoffmann H., Spear N. E. Effects of prenatal cocaine exposure on behavior during the early postnatal period. Neurotoxicol Teratol. 1989 Jan-Feb;11(1):57–63. doi: 10.1016/0892-0362(89)90086-x. [DOI] [PubMed] [Google Scholar]
  38. Spear L. P., Kirstein C. L., Frambes N. A. Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies. Ann N Y Acad Sci. 1989;562:290–307. doi: 10.1111/j.1749-6632.1989.tb21027.x. [DOI] [PubMed] [Google Scholar]
  39. Spear L. P., Kirstein C. L., Frambes N. A., Moody C. A. Neurobehavioral teratogenicity of gestational cocaine exposure. NIDA Res Monogr. 1989;95:232–238. [PubMed] [Google Scholar]
  40. Stead A. H., Moffat A. C. A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum Toxicol. 1983 Jul;2(3):437–464. doi: 10.1177/096032718300200301. [DOI] [PubMed] [Google Scholar]
  41. Stewart D. J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther. 1979 Apr;25(4):464–468. doi: 10.1002/cpt1979254464. [DOI] [PubMed] [Google Scholar]
  42. Volpe J. J. Effect of cocaine use on the fetus. N Engl J Med. 1992 Aug 6;327(6):399–407. doi: 10.1056/NEJM199208063270607. [DOI] [PubMed] [Google Scholar]
  43. Warren S., Chute R. N. Pheochromocytoma. Cancer. 1972 Feb;29(2):327–331. doi: 10.1002/1097-0142(197202)29:2<327::aid-cncr2820290210>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  44. Webster W. S., Brown-Woodman P. D. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology. 1990 Jun;41(6):689–697. doi: 10.1002/tera.1420410605. [DOI] [PubMed] [Google Scholar]
  45. Wiggins R. C., Rolsten C., Ruiz B., Davis C. M. Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation. Neurotoxicology. 1989 Fall;10(3):367–381. [PubMed] [Google Scholar]
  46. Wiggins R. C., Ruiz B. Development under the influence of cocaine. II. Comparison of the effects of maternal cocaine and associated undernutrition on brain myelin development in the offspring. Metab Brain Dis. 1990 Jun;5(2):101–109. doi: 10.1007/BF01001050. [DOI] [PubMed] [Google Scholar]
  47. el-Bizri H., Guest I., Varma D. R. Effects of cocaine on rat embryo development in vivo and in cultures. Pediatr Res. 1991 Feb;29(2):187–190. doi: 10.1203/00006450-199102000-00017. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES